Severe Euglycemic diabetic ketoacidosis with mixed Acid-Base disorder following acetazolamide initiation in type 2 diabetes: a case report and review of literature
{{output}}
Euglycemic diabetic ketoacidosis (euDKA) is an increasingly recognized complication of sodium-glucose cotransporter-2 (SGLT2) inhibitor therapy, characterized by severe metabolic acidosis with near-normal blood glucose levels. We report a rare case of a 45-yea... ...
